Botox therapy for refractory chronic migraine

Headache

Volumn 45, Issue 4, 2005, Pages 355-357

  Conway, Stafford ^a   Delplanche, Curtis ^a   Crowder, Jessica ^a   Rothrock, John ^a  

^a Univ of S Alabama Headache Center   (United States)

Author keywords

BOTOX; Botulinum toxin type A; Chronic migraine

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PROPHYLAXIS; TRANSFORMED MIGRAINE; TREATMENT OUTCOME;

ADULT; AGED; BOTULINUM TOXIN TYPE A; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROMUSCULAR AGENTS; TREATMENT FAILURE;

EID: 17244372487     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05073a.x     Document Type: Article

References (13)

1. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497-506.
2. Mathew NT. Chronic refractory headache. Neurology. 1993;43:S26-S33.
3. Rothrock JF, Kelly NM, Brody ML, Golbeck A. A differential response to treatment with divalproex sodium in patients with intractable headache. Cephalalgia. 1994;14:241-244.
4. Saper JR, Lake III AE, Cantrell DT, Winner P, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache. 2002;42:470-482.
5. Spira PJ, Beran RG. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology. 2003;61:1753-1759.
6. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia. 2003;23: 820-824.
7. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34:1-7.
8. Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40:853-860.
9. Blumenfeld A. Botulinum toxin A for the treatment of headache: pro. Headache. 2004;44:825-830.
10. Welch KMA. Botulinum toxin type A for the treatment of headache: con. Headache. 2004;44:831-833.
11. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995;52:281-286.
12. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291:965-973.
13. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61:490-495.